世界中の市場調査レポートを販売！当社に無いレポートもお探しします。

レポートナンバー　0000036221

診断・検査薬
医療器具・機器

腫瘍マーカー検査の世界市場（2023〜2027年）- がん診断検査および分析装置の高成長機会 - 92カ国の分析 - サプライヤーのシェアと戦略、主要腫瘍マーカーの検査量と売上セグメントの予測、最新技術と機器パイプライン、サプライヤーの新たな機会

VPGMarketResearch

2023-2027 World Tumor Marker Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--A 92-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

発刊日 2023/09/25

言語英語

体裁PDF

ライセンス/価格

0000036221

Local PDF
Global PDF
DataPack

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

お問い合わせ
サンプル依頼

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

この新しい92カ国のレポートは、地域、国、市場セグメント、セクション、個々のマーカー別に入手でき、特定の情報ニーズや予算に合わせてカスタマイズすることが可能です。

本レポートは、診断業界の幹部や、ダイナミックで急速に拡大するがん診断検査市場への多角化を計画している企業が、今後 5 年間の新たな機会を評価し、効果的なビジネス戦略を開発するのに役立つように設計されています。

本レポートでは、40 を超える腫瘍マーカーについての詳細な市場セグメンテーション分析と予測の提供、革新的な技術と製品を備えた主要なサプライヤーと最近の市場参入者の紹介、現在および新たなアッセイのレビュー、現在の機器のレビュー、新しい技術の評価、サプライヤーに具体的な機会と成長戦略の提供を可能にします。

論理的根拠

研究者らが腫瘍の診断と治療における大きな技術的進歩に近づき、新たな特異抗原を発見し、病気の遺伝的基盤の謎を解明するにつれて、がん診断市場は爆発寸前となっています。今後 5 年間で、世界のがん診断市場は刺激的でダイナミックかつ急速に拡大する分野になることが予想されます。予想される技術的進歩により、遺伝的素因の決定、特定の腫瘍の検出、がん治療に対する生物学的反応のモニタリングのための多くの機会が生み出されるでしょう。高齢者人口の増加は、悪性腫瘍検査に対する需要の高まりと世界中での急速な市場の拡大をさらに複雑にするでしょう。

調査範囲

  • 調査地域
    ➣ アジア太平洋
    ➣ ヨーロッパ
    ➣ ラテンアメリカ
    ➣ 中東
    ➣ 北アメリカ
  • 調査国
    アルバニア、アルゼンチン、オーストラリア、オーストリア、バーレーン、バングラデシュ、ベラルーシ、ベルギー、ボリビア、ブラジル、ブルガリア、カナダ、チリ、中国、コロンビア、コスタリカ、クロアチア、キューバ、キプロス、チェコ共和国、デンマーク、ドミニカ共和国、エクアドル、エルサルバドール、エジプト、エストニア、フィンランド、フランス、ジョージア、ドイツ、ガーナ、ギリシャ、グアテマラ、ハイチ、ホンジュラス、香港、ハンガリー、アイスランド、インド、インドネシア、イラン、イラク、アイルランド、イスラエル、イタリア、ジャマイカ、日本、ヨルダン、カザフスタン、ケニア、クウェート、ラトビア、レバノン、リトアニア、マレーシア、マルタ、メキシコ、モルドバ、モロッコ、ミャンマー、オランダ、ニュージーランド、ニカラグア、ナイジェリア、ノルウェー、オマーン、パキスタン、パナマ、パラグアイ、ペルー、フィリピン、ポーランド、ポルトガル、プエルトリコ、カタール、ルーマニア、ロシア、サウジアラビア、セルビア、シンガポール、スロバキア、スロベニア、南アフリカ、韓国、スペイン、スウェーデン、スイス、台湾、タイ、トルコ、イギリス、ウクライナ、アラブ首長国連邦、ウルグアイ、アメリカ、ベネズエラ、ベトナム
  • ビジネスチャンスと戦略的提言
    ➣ 今後 5 年間に市場に大きな魅力をもたらす可能性がある特定の新製品開発の機会
    ➣ 新製品の設計基準
    ➣ 市場浸透のための代替戦略
    ➣ 潜在的な市場参入障壁とリスク
  • 200 を超える現在および新興のがん診断検査
    ➣ がん遺伝子
    ➣ 生化学マーカー
    ➣ 成長因子
    ➣ コロニー刺激因子
    ➣ ホルモン
    ➣ 免疫組織化学的染色
    ➣ リンホカイン
    ➣ ACTH、AFP、ベータ-2 ミクログロブリン、CA 15-3/27.29、CA 19-9、CA 125、カルシトニン、カテプシン、CEA、クロモグラニン、結腸特異抗原、サイトケラチン、エストロゲン受容体、フェリチン、ガストリン、HCG、インスリン、インターフェロン、インターロイキン、リンパ球サブタイピング、ニューロン特異的エノラーゼ、核小体、潜血、がん遺伝子、膵臓癌胎児性抗原、パプスメア、副甲状腺ホルモン、プロゲステロン受容体、前立腺酸ホスファターゼ、前立腺特異抗原、S-100タンパク質、セロトニン、シアル酸、扁平上皮癌抗原、TDT、チミジンキナーゼ、チログロブリン、組織ポリペプチド抗原など
  • サプライヤーのシェア、売上高、検査量の予測
    ➣ 主要国の主要ながん診断製品サプライヤーの個別検査別の売上高および市場シェア
    ➣ 主要ながん診断アッセイの 5 年間の検査量と売上予測
  • 機器のレビュー
    ➣ がん検査に使用される主要な分子診断および免疫診断分析装置の動作特性、機能、販売価格などの分析
  • 技術評価
    ➣ 最新技術とその潜在的な癌診断検査への応用の評価
    ➣ 競合/補完技術のレビュー
    ➣ 新しいがんの診断検査および検出技術を開発している企業、大学、研究センター
  • 競争戦略
    ➣ 革新的ながん診断技術および製品を開発している主要なサプライヤーおよび新興企業の戦略的評価（販売、製品ポートフォリオ、マーケティング戦術、協力体制、研究開発における新製品など）
  • 調査企業
    ➣ Abbott
    ➣ Affymetrix
    ➣ Beckman Coulter/Danaher/Cepheid
    ➣ Becton Dickinson
    ➣ bioMerieux
    ➣ Bio-Rad
    ➣ DiaSorin
    ➣ 栄研化学（Eiken Chemical）
    ➣ Elitech Group
    ➣ Enzo Biochem
    ➣ 富士フイルム和光（Fujifilm Wako）
    ➣ 富士レビオ（Fujirebio）
    ➣ Grifols
    ➣ Hologic
    ➣ Leica Biosystems
    ➣ Perkin Elmer
    ➣ Qiagen
    ➣ QuidelOrtho
    ➣ Roche
    ➣ Siemens Healthineers
    ➣ タカラバイオ（Takara Bio）
    ➣ Thermo Fisher

レポート詳細

目次

Table of Contents

I. Introduction

II. Worldwide Market Overview

III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies

VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. Worldwide Market and Technology Overview
A. Cancer Statistics and Etiology
　1. Breast Cancer
　2. Lung Cancer
　3. Colon and Rectum Cancer
　4. Prostate Cancer
　5. Stomach Cancer
　6. Leukemia
　7. Lymphoma
　8. Oral Cancer
　9. Skin Cancer
　10. Uterine Cancer
　11. Ovarian Cancer
　12. Bladder Cancer
B. Major Current and Emerging Cancer Diagnostic Tests
　1. Introduction
　2. Tumor Marker Classification
　3. ACTH
　4. Alpha-Fetoprotein (AFP)
　5. Beta-2 Microglobulin
　6. CA 15-3/27.29
　7. CA 19-9
　8. CA-125
　9. Calcitonin
　10. Carcinoembrionic Antigen (CEA)
　11. Estrogen and Progesterone Receptors
　12. Ferritin
　13. Gastrin
　14. Human Chorionic Gonadotropin (HCG)
　15. Insulin
　16. NSE
　17. Occult Blood
　18. PAP Smear/HPV
　19. Prostatic Acid Phosphatase (PAP)
　20. Prostate-Specific Antigen (PSA)
　21. Squamous Cell Carcinoma Antigen (SCC)
　22. T and B Lymphocytes
　23. TdT
　24. Thyroglobulin
　25. Tissue Polypeptide Antigen (TPA)
　26. Biochemical Tumor Markers
　27. Oncogenes
　　　- Abl/abl-bcr
　　　- AIB1
　　　- BCL-2
　　　- BRCA1
　　　- CD44
　　　- C-fos
　　　- C-myb
　　　- C-myc
　　　- CYP-17
　　　- Erb-B
　　　- HPC1
　　　- N-myc
　　　- P40
　　　- P51
　　　- P53
　　　- PIK3CA
　　　- PTI-1
　　　- Ras
　　　- Reg
　　　- Sis
　　　- Src and others
　28. Polypeptide Growth Factors
　　　- Basic Fibroblast Growth Factor
　　　- Beta-TGF
　　　- Cachectin (TNT)
　　　- Calmodulin
　　　- ECFR
　　　- Nerve Growth Factor (NGF)
　　　- Epidermal Growth Factor (EGF)
　　　- Ornithine Decarboxylase
　　　- Transferrin
　　　- Transforming Growth Factor-Alpha
　29. Ectopic Hormones
　30. Colony Stimulating Factors
　31. Lymphokines
　　　- Alpha-Interferon
　　　- B Cell Growth Factors
　　　- B Cell Growth Factor (BCGF)
　　　- Gamma-Interferon
　　　- Interleukin-1 (IL-1)
　　　- Macrophage Activating Factor
　32. Immunohistochemical Stains
　33. Emerging Tumor Markers
　　　- N-Acetylglucosamine
　　　- Actin
　　　- Alpha-Actin
　　　- Antineuronal Antibodies
　　　- 7B2
　　　- B72.3
　　　- Bax
　　　- BCD-F9
　　　- BLCA-4
　　　- Blood Group Antigens A,B,H
　　　- CA 50
　　　- CA 72-4/TAG-72
　　　- CA 195
　　　- CA-242
　　　- CA-549
　　　- CAM 26
　　　- CAR-3
　　　- Cathepsin-D
　　　- Chromogranin A and B
　　　- Cluster 1 Antigen
　　　- Cluster-5/5A Antigen
　　　- CTA
　　　- CU18
　　　- DR-70
　　　- DU-PAN-2
　　　- Endometrial Bleeding Associated Factor
　　　- Endostatin
　　　- Epithelial Membrane Antigen
　　　- Feulgen Hydrolysis
　　　- Fibronectin
　　　- FSH
　　　- (1->3)-L-fucosyltransferase
　　　- Gastrin-Releasing Peptide (GRP)
　　　- GDCFP-15
　　　- Glucagon
　　　- Glycoamines
　　　- H23
　　　- Her-2
　　　- Human Carcinoma Antigen
　　　- HPA
　　　- HSP27
　　　- Intermediate Filaments
　　　- Cytokeratins/CK18/Cyfra 21-1
　　　- Desmin
　　　- Gliofibrillary Acid Protein
　　　- Neurofilaments
　　　- Vimentin
　　　- KA 93
　　　- Kinases
　　　- KP16D3
　　　- LAI
　　　- Leukocyte Common Antigen
　　　- Lewis Antigens
　　　- Lysophosphatidic Acid (LPA)
　　　- Ma 695/Ma 552
　　　- MABDF3
　　　- MAG
　　　- ME1
　　　- Minactivin
　　　- MN/CA9
　　　- MSA
　　　- Mucin Cancer Antigen (MCA)
　　　- Multiple Tumor Suppressor 1
　　　- Myosin
　　　- NEA-130
　　　- NMP22
　　　- OA-519
　　　- Opioid Peptides
　　　- P-glycoprotein
　　　- Pancreatic Oncofetal Antigen (POA)
　　　- Placental Lactogen
　　　- PR92
　　　- Proliferative Index, Ki-67
　　　- Px
　　　- RB Inactivation/Deletion
　　　- Ret
　　　- SCCL 175
　　　- Selectin
　　　- Sialic Acid
　　　- Sialyl SSEA-1/SLX
　　　- SN10
　　　- Somatostatin
　　　- TA-90
　　　- TABA
　　　- Tachykinin
　　　- TAG 12
　　　- TPS
　　　- Troponin
　　　- Tubulin
　　　- VCAM
　　　- VEGF
　　　- Villen and others
C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
　1. Monoclonal and Polyclonal Antibodies
　2. Immunoassays
　3. Molecular Diagnostics
　4. Chromosome Analysis
　　a. Chronic Myelogenous Leukemia (CML)
　　b. Acute Myeloid Leukemia (AML)
　　c. Acute Lymphoblastic Leukemia (ALL)
　　d. Malignant Lymphomas Lymphoid Malignancies
　　e. Chronic Lymphocytic Leukemia (CLL)
　　f. Solid Cancers
　　g. Chromosomal Translocation and Oncogenes
　5. Artificial Intelligence
　6. Flow Cytometry
　7. Two Dimensional Gel Electrophoresis (2-DGE)
　8. Biosensors
　9. Competing/Complementing Technologies
E. Personal Testing

VIII. Country Market Analyses: Cancer Diagnostics Market Test
Volume and Sales Forecasts for 97 Countries:
Albania, Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Moldova, Morocco, Myanmar, Netherlands, New
Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovak Republic, Slovenia, South Korea, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela, Vietnam

IX. Competitive Profiles
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
　　　- Abbott
　　　- Affymetrix
　　　- Beckman Coulter/Danaher/Cepheid
　　　- Becton Dickinson
　　　- bioMerieux
　　　- Bio-Rad
　　　- DiaSorin
　　　- Eiken Chemical
　　　- Elitech Group
　　　- Enzo Biochem
　　　- Fujifilm Wako
　　　- Fujirebio
　　　- Grifols
　　　- Hologic/Gen-Probe
　　　- Leica Biosystems/Kreatech
　　　- Qiagen
　　　- QuidelOrtho
　　　- Roche
　　　- Siemens Healthineers
　　　- Takara Bio
　　　- Thermo Fisher and others

List of Tables
Argentina Cancer Diagnostic Volume Forecasts by Test
Argentina Cancer Diagnostics Sales Forecasts by Test
Australia Cancer Diagnostic Volume Forecasts by Test
Australia Cancer Diagnostics Sales Forecasts by Test
Austria Cancer Diagnostic Volume Forecasts by Test
Austria Cancer Diagnostics Sales Forecasts by Test
Bahrain Cancer Diagnostic Volume Forecasts by Test
Bahrain Cancer Diagnostics Sales Forecasts by Test
Bangladesh Cancer Diagnostic Volume Forecasts by Test
Bangladesh Cancer Diagnostics Sales Forecasts by Test
Belgium Cancer Diagnostic Volume Forecasts by Test
Belgium Cancer Diagnostics Sales Forecasts by Test
Brazil Cancer Diagnostic Volume Forecasts by Test
Brazil Cancer Diagnostics Sales Forecasts by Test
Bulgaria Cancer Diagnostic Volume Forecasts by Test
Bulgaria Cancer Diagnostics Sales Forecasts by Test
Canada Cancer Diagnostic Volume Forecasts by Test
Canada Cancer Diagnostics Sales Forecasts by Test
Chile Cancer Diagnostic Volume Forecasts by Test
Chile Cancer Diagnostics Sales Forecasts by Test
China Cancer Diagnostic Volume Forecasts by Test
China Cancer Diagnostics Sales Forecasts by Test
Colombia Cancer Diagnostic Volume Forecasts by Test
Colombia Cancer Diagnostics Sales Forecasts by Test
Croatia Cancer Diagnostic Volume Forecasts by Test
Croatia Cancer Diagnostics Sales Forecasts by Test
Cyprus Cancer Diagnostic Volume Forecasts by Test
Cyprus Cancer Diagnostics Sales Forecasts by Test
Czech Republic Cancer Diagnostic Volume Forecasts by Test
Czech Republic Cancer Diagnostics Sales Forecasts by Test
Denmark Cancer Diagnostic Volume Forecasts by Test
Denmark Cancer Diagnostics Sales Forecasts by Test
Egypt Cancer Diagnostic Volume Forecasts by Test
Egypt Cancer Diagnostics Sales Forecasts by Test
Estonia Cancer Diagnostic Volume Forecasts by Test
Estonia Cancer Diagnostics Sales Forecasts by Test
Finland Cancer Diagnostic Volume Forecasts by Test
Finland Cancer Diagnostics Sales Forecasts by Test
France Executive Summary Table: Total Cancer
Diagnostic Test Volume and Sales Forecast by Market Segment
France, Estimated Cancer Death Rates
Per 100,000 Population
France, Laboratories Performing Tumor
Marker Tests by Market Segment
France, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories
Performing Tumor Markers by Annual Test Volume
France, Total Tumor Marker Test Volume
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories
Marker Test Volume Forecast
France, Total Tumor Marker Sales Major Tumor
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
France, Commercial/Private Laboratories Cancer
Diagnostics Market Forecast by Test
France, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
France, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
France, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market
France, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
France, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
France, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
France, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
France, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
France, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
France, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
France, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
France, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
France, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
France, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, S-100 Protein Test Volume and Sales
Diagnostics Sales Forecast by Market Segment
France, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
France, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
France, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by
Market Segment
France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
France, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
France, Total Tumor Marker Sales by Major Suppliers
France, AFP Testing Market Diagnostics
Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics
Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
France, CA 125 Testing Market Diagnostics
Sales by Major Supplier
France, CEA Testing Market Diagnostics
Sales by Major Supplier
France, NSE Testing Market Diagnostics
Sales by Major Supplier
France, PAP Testing Market Diagnostics
Sales by Major Supplier
France, PSA Testing Market Diagnostics
Sales by Major Supplier
Germany Executive Summary Table: Total
Tumor Marker Test Volume and Sales Forecast by Market Segment
Germany, Estimated Cancer Death Rates
Per 100,000 Population
Germany, Laboratories Performing Tumor
Marker Tests by Market Segment
Germany, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories
Performing Tumor Markers by Annual Test Volume
Germany, Total Tumor Marker Test Volume
Forecast by Market Segment
Germany, All Market Segments, Major Tumor
Marker Test Volume Forecast
Germany, Hospital Laboratories, Major
Tumor Marker Test Volume Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Germany, Physician Offices/Group
Practices Major Tumor Marker
Test Volume Forecast
Germany, Total Tumor Marker Sales
Forecast by Market Segment
Germany, All Market Segments Major Tumor
Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor
Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA-19 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Calcitonin Test Volume and Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, HCG, Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales by Major Supplier
Germany, AFP Testing Market Diagnostics
Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Germany, CEA Testing Market Diagnostics
Sales by Major Supplier
Germany, PSA Testing Market Diagnostics
Sales by Major Supplier
Ghana Cancer Diagnostic Volume Forecasts by Test
Ghana Cancer Diagnostics Sales Forecasts by Test
Greece Cancer Diagnostic Volume Forecasts by Test
Greece Cancer Diagnostics Sales Forecasts by Test
Hong Kong Cancer Diagnostic Volume Forecasts by Test
Hong Kong Cancer Diagnostics Sales Forecasts by Test
Hungary Cancer Diagnostic Volume Forecasts by Test
Hungary Cancer Diagnostics Sales Forecasts by Test
Iceland Cancer Diagnostic Volume Forecasts by Test
Iceland Cancer Diagnostics Sales Forecasts by Test
India Cancer Diagnostic Volume Forecasts by Test
India Cancer Diagnostics Sales Forecasts by Test
Indonesia Cancer Diagnostic Volume Forecasts by Test
Indonesia Cancer Diagnostics Sales Forecasts by Test
Iran Cancer Diagnostic Volume Forecasts by Test
Iran Cancer Diagnostics Sales Forecasts by Test
Iraq Cancer Diagnostic Volume Forecasts by Test
Iraq Cancer Diagnostics Sales Forecasts by Test
Ireland Cancer Diagnostic Volume Forecasts by Test
Ireland Cancer Diagnostics Sales Forecasts by Test
Israel Cancer Diagnostic Volume Forecasts by Test
Israel Cancer Diagnostics Sales Forecasts by Test
Italy Executive Summary Table: Total Tumor
Marker Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Estimated Cancer Death Rates
Per 100,000 Population
Italy, Laboratories Performing Tumor
Marker Tests by Market Segment
Italy, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories
Performing Tumor Markers by Annual
Test Volume
Italy, Total Tumor Marker Test Volume
Forecast by Market Segment
Italy, All Market Segments Major Cancer
Diagnostic Test Volume Forecast
Italy, Hospital Laboratories Major Tumor
Marker Test Volume Forecast
Italy, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Italy, Total Tumor Marker Test Market
Forecast by Market Segment
Italy, All Market Segments Major Tumor
Marker Sales Forecast by Test
Italy, Hospital Laboratories Major
Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
Italy, ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment

Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CA 125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Colon Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Occult Blood Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Pancreatic Oncofetal Antigen Test
Volume and Diagnostics Sales Forecast by Market Segment
Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, PSA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, S-100 Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test
Volume and Diagnostics Sales Forecast by Market Segment
Italy, TDT Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, TPA Test Volume and Diagnostics Sales
Forecast by Market Segment
Italy, Total Tumor Markers
Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics
Sales by Major Supplier
Italy, CEA Testing Market Diagnostics
Sales by Major Supplier
Italy, PSA Testing Market Diagnostics
Sales by Major Supplier
Japan Executive Summary Table: Total Tumor
Marker Test Volume and Sales Forecast by Market Segment
Japan, Estimated Cancer Death Rates
Per 100,000 Population
Japan, Laboratories Performing Tumor
Marker Tests by Market Segment
Japan, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Japan, Commercial/Private Laboratories
Performing Tumor Marker Tests by Annual Test Volume
Japan, Total Tumor Marker Testing Volume
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Test Volume Forecast
Japan, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
Japan, Commercial/Private Laboratories Major
Tumor Marker Test Volume Forecast
Japan, Total Tumor Marker Sales
Forecast by Market Segment
Japan, All Market Segments Major Tumor
Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Japan, ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, HCG Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, NSE Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Japan, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, PAP Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, TPA, Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan, Total Tumor Marker
Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics
Sales by Major Supplier
Japan, PAP Testing Market Diagnostics
Sales by Major Supplier
Japan, PSA Testing Market Diagnostics
Sales by Major Supplier
Jordan Cancer Diagnostic Volume Forecasts by Test
Jordan Cancer Diagnostics Sales Forecasts by Test
Kenya Cancer Diagnostic Volume Forecasts by Test
Kenya Cancer Diagnostics Sales Forecasts by Test
Kuwait Cancer Diagnostic Volume Forecasts by Test
Kuwait Cancer Diagnostics Sales Forecasts by Test
Latvia Cancer Diagnostic Volume Forecasts by Test
Latvia Cancer Diagnostics Sales Forecasts by Test
Lebanon Cancer Diagnostic Volume Forecasts by Test
Lebanon Cancer Diagnostics Sales Forecasts by Test
Lithuania Cancer Diagnostic Volume Forecasts by Test
Lithuania Cancer Diagnostics Sales Forecasts by Test
Malaysia Cancer Diagnostic Volume Forecasts by Test
Malaysia Cancer Diagnostics Sales Forecasts by Test
Malta Cancer Diagnostic Volume Forecasts by Test
Malta Cancer Diagnostics Sales Forecasts by Test
Mexico Cancer Diagnostic Volume Forecasts by Test
Mexico Cancer Diagnostics Sales Forecasts by Test
Morocco Cancer Diagnostic Volume Forecasts by Test
Morocco Cancer Diagnostics Sales Forecasts by Test
Myanmar Cancer Diagnostic Volume Forecasts by Test
Myanmar Cancer Diagnostics Sales Forecasts by Test
Netherlands Cancer Diagnostic Volume Forecasts by Test
Netherlands Cancer Diagnostics Sales Forecasts by Test
New Zealand Cancer Diagnostic Volume Forecasts by Test
New Zealand Cancer Diagnostics Sales Forecasts by Test
Nigeria Cancer Diagnostic Volume Forecasts by Test
Nigeria Cancer Diagnostics Sales Forecasts by Test
Norway Cancer Diagnostic Volume Forecasts by Test
Norway Cancer Diagnostics Sales Forecasts by Test
Oman Cancer Diagnostic Volume Forecasts by Test
Oman Cancer Diagnostics Sales Forecasts by Test
Pakistan Cancer Diagnostic Volume Forecasts by Test
Pakistan Cancer Diagnostics Sales Forecasts by Test
Peru Cancer Diagnostic Volume Forecasts by Test
Peru Cancer Diagnostics Sales Forecasts by Test
Philippines Cancer Diagnostic Volume Forecasts by Test
Philippines Cancer Diagnostic Volume Forecasts by Test
Poland Cancer Diagnostics Sales Forecasts by Test
Poland Cancer Diagnostic Volume Forecasts by Test
Portugal Cancer Diagnostics Sales Forecasts by Test
Portugal Cancer Diagnostic Volume Forecasts by Test
Qatar Cancer Diagnostic Volume Forecasts by Test
Qatar Cancer Diagnostics Sales Forecasts by Test
Romania Cancer Diagnostic Volume Forecasts by Test
Romania Cancer Diagnostics Sales Forecasts by Test
Saudi Arabia Cancer Diagnostic Volume Forecasts by Test
Saudi Arabia Cancer Diagnostics Sales Forecasts by Test
Serbia Cancer Diagnostic Volume Forecasts by Test
Serbia Cancer Diagnostics Sales Forecasts by Test
Singapore Cancer Diagnostic Volume Forecasts by Test
Singapore Cancer Diagnostics Sales Forecasts by Test
Slovakia Cancer Diagnostic Volume Forecasts by Test
Slovakia Cancer Diagnostics Sales Forecasts by Test
Slovenia Cancer Diagnostic Volume Forecasts by Test
Slovenia Cancer Diagnostics Sales Forecasts by Test
South Africa Cancer Diagnostic Volume Forecasts by Test
South Africa Cancer Diagnostics Sales Forecasts by Test
South Korea Cancer Diagnostic Volume Forecasts by Test
South Korea Cancer Diagnostics Sales Forecasts by Test
Spain Executive Summary Table: Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
Spain, Estimated Cancer Death Rates
Per 100,000 Population
Spain, Laboratories Performing Tumor
Marker Tests by Market Segment
Spain, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories
Performing Tumor Markers by
Annual Test Volume
Spain, Total Tumor Marker Test Volume
Forecast by Market Segment
Spain, All Market Segment Major Cancer
Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecast by Test
Spain, Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales
Forecast by Market Segment
Spain, All Market Segments Major Tumor
Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major
Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Progesterone Receptor
Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain, PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by Major Suppliers
Spain, AFP Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Spain, CEA Testing Market Diagnostics
Sales by Major Supplier
Spain, PSA Testing Market Diagnostics
Sales by Major Supplier
Sweden Cancer Diagnostic Volume Forecasts by Test
Sweden Cancer Diagnostics Sales Forecasts by Test
Switzerland Cancer Diagnostic Volume Forecasts by Test
Switzerland Cancer Diagnostics Sales Forecasts by Test
Taiwan Cancer Diagnostic Volume Forecasts by Test
Taiwan Cancer Diagnostics Sales Forecasts by Test
Thailand Cancer Diagnostic Volume Forecasts by Test
Thailand Cancer Diagnostics Sales Forecasts by Test
U.K. Executive Summary Table: Total
Tumor Marker Test Volume and Sales
Forecast by Market Segment
U.K., Estimated Cancer Death Rates
Per 100,000 Population
U.K., Laboratories Performing Tumor
Marker Tests by Market Segment
U.K., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories
Performing Tumor Marker Tests by
Annual Test Volume
U.K., Total Tumor Marker Testing Volume
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major
Tumor Marker Test Volume
Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.K., Total Tumor Marker Sales
Forecast by Market Segment
U.K., All Market Segments Major
Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major
Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.K., ACTH Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., AFP Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CEA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Chromogranin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Colon-Specific Antigen Test Volume and Diagnostics Sales by Market Segment
U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Thyroglobulin
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K., Total Tumor Marker Sales and Market Shares Forecast
U.K., CEA Testing Market Diagnostics
Sales by Major Supplier
U.K., PSA Testing Market Diagnostics
Sales by Major Supplier
United Arab Emirates Cancer Diagnostic Volume Forecasts by Test
United Arab Emirates Cancer Diagnostics Sales Forecasts by Test
U.S.A. Executive Summary Table: Total Tumor
Marker Test Volume and Sales Forecast by Market Segment
U.S.A., Estimated New Cancer Cases and Deaths
U.S.A., Estimated Cancer Death Rates
Per 100,000 Population
U.S.A., Laboratories Performing Tumor
Marker Tests by Market Segment
U.S.A., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.S.A., Commercial/Private Laboratories
Performing Tumor Marker Tests by Annual Test Volume
U.S.A., Physician Office Laboratories
Performing Tumor Marker Tests by Practice Size
U.S.A., Total Tumor Marker Test Volume
Forecast by Market Segment
U.S.A., All Market Segments Major
Tumor Marker Test Volume Forecast
U.S.A., Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
U.S.A., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Major Tumor Marker Test Volume Forecast
U.S.A., Cancer Clinics Major Tumor
Marker Test Volume Forecast by Test
U.S.A., Total Tumor Marker Sales
Forecast by Market Segment
U.S.A., All Market Segment Major Tumor
Marker Sales Forecast by Test
U.S.A., Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
U.S.A., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.S.A., Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
U.S.A., Cancer Clinics Major Tumor
Marker Sales Forecast by Test
U.S.A., ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., CEA Test Volume and Diagnostics
Sales by Market Segment
U.S.A., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Colon-specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Sialic Acid Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Thyroglobulin Test
Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Total Tumor Marker Sales by Major Supplier
U.S.A., ACTH Testing Market Diagnostics
Sales by Major Supplier
U.S.A., AFP Testing Market Diagnostics
Sales by Major Supplier
U.S.A., Beta-2 Migroblolulin Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CA 19-9 Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CA 125 Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CEA Testing Market
Diagnostics Sales by Major Supplier
U.S.A., Ferritin Testing Market
Diagnostics Sales by Major Supplier
U.S.A., HCG Testing Market
Diagnostics Sales by Major Supplier
U.S.A., Insulin Testing Market
Diagnostics Sales by Major Supplier
U.S.A., Parathyroid Hormone Testing Market
Diagnostics Sales by Major Supplier
U.S.A., PAP Testing Market Diagnostics
Sales by Major Supplier
U.S.A., Progesterone Receptor Testing Market
Diagnostics Sales by Major Supplier
U.S.A., PSA Testing Market Diagnostics
Sales by Major Supplier
Venezuela Cancer Diagnostic Volume Forecasts by Test
Venezuela Cancer Diagnostics Sales Forecasts by Test
Vietnam Cancer Diagnostic Volume Forecasts by Test
Vietnam Cancer Diagnostics Sales Forecasts by Test
Tumor Marker Classification
Major Companies Developing or
Marketing ACTH Tests
Major Companies Developing or
Marketing AFP Tests
Major Companies Developing or
Marketing Beta-2 Microglobulin Tests
Major Companies Developing or
Marketing CA 15-3/27.29 Tests
Major Companies Developing or
Marketing CA 19-9 Tests
Major Companies Developing or
Marketing CA 125 Tests
Major Companies Developing or
Marketing Calcitonin Tests
Major Companies Developing or
Marketing CEA Tests
Major Companies Developing or
Marketing Estrogen Receptor Tests
Major Companies Developing or
Marketing Progesterone Receptor Tests
Major Companies Developing or
Marketing Ferritin Tests
Major Companies Developing or
Marketing Gastrin Tests
Major Companies Developing or
Marketing HCG Tests
Major Companies Developing or
Marketing Insulin Tests
Major Companies Developing or
Marketing NSE Tests
Major Companies Developing or
Marketing Occult Blood Tests
Major Companies Developing or
Marketing PAP Smear/HPV Tests
Major Companies Developing or
Marketing PAP Tests
Major Companies Developing or
Marketing PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or
Marketing Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications
in Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis

お買い物ガイド
よくある質問

この商品のレポートナンバー

0000036221

会員登録
TOP